DD News and Press, E.I. du Pont de Nemours and Company From 01/29/24

2024-01-29 13:15:49 ET More on Markets Inflation, politics and household finances are top concerns for consumers – Morgan Stanley Oil breaks above technical resistance and has upside room to $85 per barrel - BTIG Taylor Swift might just save us from ourselves,...

2024-01-28 10:54:40 ET Summary DuPont de Nemours stock has performed poorly in the past 5 years, down over 20%. Recent weak demand in China has caused sales and earnings to fall below analysts' estimates. With the recent share price decline, now may be the perfect opportunity ...

2024-01-26 16:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-25 18:08:00 ET Shares of DuPont (NYSE: DD) are down 13% this week as of Thursday's close, according to data provided by S&P Global Market Intelligence , after the global chemical company announced mixed preliminary fourth-quarter results and disappointing forward gui...

2024-01-25 14:20:28 ET Summary DOW has a high starting dividend yield of 5% and has a double-digit price upside when the market shifts. Despite a challenging economic backdrop, Dow reported better-than-expected earnings, with a non-GAAP EPS of $0.43. Dow's strategic projects a...

2024-01-24 13:33:39 ET More on DuPont DuPont: Less Future Potential (Rating Downgrade) DuPont: Avoid This Blue Chip Following Weak Q3 Results DuPont Stock: We Have Some Highlights Going Into FY23 DuPont's stock plunges on warning of slow sales, China weakness...

2024-01-24 11:09:58 ET Chemicals giant DuPont de Nemours (NYSE: DD) is seeing demand soften, both from Western industrial customers and from China. That's impacting earnings, and investors are not happy. Shares of DuPont traded down 12% as of 10:30 a.m. ET Wednesday after the co...

2024-01-24 08:40:30 ET Losers: Theratechnologies THTX -30% says FDA rejected new Egrifta version . Annovis Bio ( ANVS ) -11% refines timeline for Parkinson’s phase III study data announcement . BlackBerry Ltd BB -11% announces proposed private ...

2024-01-24 08:22:16 ET More on DuPont DuPont: Less Future Potential (Rating Downgrade) DuPont: Avoid This Blue Chip Following Weak Q3 Results DuPont Stock: We Have Some Highlights Going Into FY23 DuPont downgraded to Underperform at Bank of America on PFAS ri...

DuPont Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides Initial First Quarter 2024 Outlook PR Newswire Schedules Quarterly Earnings Conference Call for February 6, 2024 WILMINGTON, Del. , Jan. 24, 2024 /PRNewswire/ -- DuPon...